Targeted brain chemotherapy trial for rare childhood tumors ends early
NCT ID NCT04994977
First seen Mar 30, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This early-phase trial tested giving chemotherapy directly into the brain's arteries to shrink rare choroid plexus tumors before a second surgery. Only one person enrolled before the study was stopped. The goal was to see if this approach is safe and can make tumors smaller for easier removal.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOROID PLEXUS CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Weill Cornell Medicine
New York, New York, 10025, United States
Conditions
Explore the condition pages connected to this study.